Clinical Trials · NCT07224490
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 40
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- Difference in mean luteinizing hormone (LH) amplitude between cases and controls